SIG on Formulation Design and Pharmaceutical Technology

Chair: Prof. Jayne Lawrence (United Kingdom)

Vice-Chair: Prof. Tetsuya Ozeki (Japan)

 

Overview

Safety and clinical efficacy of medicines critically depend on the availability of high quality formulations designed to achieve therapeutically-relevant pharmacokinetic drug profiles in patients. Both pharmacists and pharmaceutical scientists, either through compounding (formulating) of patient-specific dosage forms or design, research, and development of commercial drug products, are vital in facilitating access to safe and efficacious medicines across the globe every day.

Formulation Design & Pharmaceutical Technology offers a dynamic international forum for the exchange of knowledge among FIP members, who share a common interest in the design and testing of drug delivery systems. Formulation Design & Pharmaceutical Technology is a multidisciplinary SIG that focuses on aspects of conventional and novel dosage forms suitable for all routes of administration, including:

  • Pharmacy Compounding/Formulating
  • Preformulation
  • Biopharmaceutics/Molecular Pharmaceutics
  • Material Sciences/Excipients
  • Smart Drug Delivery Systems
  • Patient-specific Dosage Forms (e.g., pediatric, elderly)
  • Medical Devices/Combination Products
  • Nanotechnology
  • Quality by Design

Drawing upon physical, chemical, biological, and engineering sciences, our primary goal is to unite compounding pharmacists and pharmaceutical scientists from diverse scientific disciplines in industry, regulatory agencies, and academia with the objective to enhance their contributions to global health. With support from our membership, we develop formulation-related program activities at scientific meetings and workshops. In addition, we are committed to offer opportunities for networking, and professional development, including continuing education.

For more information please contact Prof. Lawrence at FormulationDesignPharmaceuticalTechnology@fip.org.